Matches in SemOpenAlex for { <https://semopenalex.org/work/W4213122015> ?p ?o ?g. }
- W4213122015 endingPage "94" @default.
- W4213122015 startingPage "82" @default.
- W4213122015 abstract "Atherosclerosis is characterized by inflammation in the arterial wall, which is known to be exacerbated by diabetes. Therapeutic repression of inflammation is a promising strategy for treating atherosclerosis. In this study, we showed that diabetes aggravated atherosclerosis in apolipoproteinE knockout (ApoE-/-) mice, in which increased expression of long-chain acyl-CoA synthetase 1 (Acsl1) in macrophages played an important role. Knockdown of Acsl1 in macrophages (Mφ shAcsl1 ) reprogrammed macrophages to an anti-inflammatory phenotype, especially under hyperglycemic conditions. Injection of Mφ shAcsl1 reprogrammed macrophages into streptozotocin (STZ)-induced diabetic ApoE-/- mice (ApoE-/-+ STZ) alleviated inflammation locally in the plaque, liver and spleen. Consistent with the reduction in inflammation, plaques became smaller and more stable after the adoptive transfer of reprogrammed macrophages. Taken together, our findings indicate that increased Acsl1 expression in macrophages play a key role in aggravated atherosclerosis of diabetic mice, possibly by promoting inflammation. Adoptive transfer of Acsl1 silenced macrophages may serve as a potential therapeutic strategy for atherosclerosis." @default.
- W4213122015 created "2022-02-24" @default.
- W4213122015 creator A5000698319 @default.
- W4213122015 creator A5001493292 @default.
- W4213122015 creator A5008221940 @default.
- W4213122015 creator A5010363146 @default.
- W4213122015 creator A5010611040 @default.
- W4213122015 creator A5018699150 @default.
- W4213122015 creator A5026170549 @default.
- W4213122015 creator A5033073898 @default.
- W4213122015 creator A5063265878 @default.
- W4213122015 creator A5080862307 @default.
- W4213122015 creator A5081093007 @default.
- W4213122015 creator A5085047891 @default.
- W4213122015 date "2022-10-01" @default.
- W4213122015 modified "2023-09-30" @default.
- W4213122015 title "Adoptive transfer of metabolically reprogrammed macrophages for atherosclerosis treatment in diabetic ApoE−/- mice" @default.
- W4213122015 cites W1530509485 @default.
- W4213122015 cites W1562023150 @default.
- W4213122015 cites W1970845955 @default.
- W4213122015 cites W1973444091 @default.
- W4213122015 cites W1980485314 @default.
- W4213122015 cites W1989090840 @default.
- W4213122015 cites W1995299599 @default.
- W4213122015 cites W1999732094 @default.
- W4213122015 cites W2003870922 @default.
- W4213122015 cites W2020538044 @default.
- W4213122015 cites W2025650515 @default.
- W4213122015 cites W2041663579 @default.
- W4213122015 cites W2042791841 @default.
- W4213122015 cites W2044888109 @default.
- W4213122015 cites W2054248098 @default.
- W4213122015 cites W2079386976 @default.
- W4213122015 cites W2097703150 @default.
- W4213122015 cites W2099172760 @default.
- W4213122015 cites W2101328621 @default.
- W4213122015 cites W2105724560 @default.
- W4213122015 cites W2113934014 @default.
- W4213122015 cites W2124149196 @default.
- W4213122015 cites W2137229556 @default.
- W4213122015 cites W2137563220 @default.
- W4213122015 cites W2152463906 @default.
- W4213122015 cites W2157891776 @default.
- W4213122015 cites W2160264312 @default.
- W4213122015 cites W2255567127 @default.
- W4213122015 cites W2276012049 @default.
- W4213122015 cites W2346630656 @default.
- W4213122015 cites W2401831534 @default.
- W4213122015 cites W2473550768 @default.
- W4213122015 cites W2586950898 @default.
- W4213122015 cites W2594491387 @default.
- W4213122015 cites W2596179513 @default.
- W4213122015 cites W2602144021 @default.
- W4213122015 cites W2612276016 @default.
- W4213122015 cites W2626531388 @default.
- W4213122015 cites W2795137969 @default.
- W4213122015 cites W2800530250 @default.
- W4213122015 cites W2804609215 @default.
- W4213122015 cites W2806741586 @default.
- W4213122015 cites W2807141660 @default.
- W4213122015 cites W2848978533 @default.
- W4213122015 cites W2884912010 @default.
- W4213122015 cites W2885002489 @default.
- W4213122015 cites W2887981213 @default.
- W4213122015 cites W2897460617 @default.
- W4213122015 cites W2897751115 @default.
- W4213122015 cites W2907930008 @default.
- W4213122015 cites W2912778549 @default.
- W4213122015 cites W2915480803 @default.
- W4213122015 cites W2923610452 @default.
- W4213122015 cites W2946930288 @default.
- W4213122015 cites W2955261360 @default.
- W4213122015 cites W2963724400 @default.
- W4213122015 cites W2975862998 @default.
- W4213122015 cites W2977548937 @default.
- W4213122015 cites W2981587575 @default.
- W4213122015 cites W2998275193 @default.
- W4213122015 cites W3004079464 @default.
- W4213122015 cites W3011320855 @default.
- W4213122015 cites W3083475333 @default.
- W4213122015 cites W3089283105 @default.
- W4213122015 cites W3103804121 @default.
- W4213122015 cites W3106805418 @default.
- W4213122015 cites W3109298913 @default.
- W4213122015 cites W3112004952 @default.
- W4213122015 cites W3120205736 @default.
- W4213122015 cites W3120374468 @default.
- W4213122015 cites W3122324184 @default.
- W4213122015 cites W4245018369 @default.
- W4213122015 doi "https://doi.org/10.1016/j.bioactmat.2022.02.002" @default.
- W4213122015 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35386323" @default.
- W4213122015 hasPublicationYear "2022" @default.
- W4213122015 type Work @default.
- W4213122015 citedByCount "2" @default.
- W4213122015 countsByYear W42131220152022 @default.
- W4213122015 countsByYear W42131220152023 @default.
- W4213122015 crossrefType "journal-article" @default.
- W4213122015 hasAuthorship W4213122015A5000698319 @default.